Michelson Medical Research Foundation Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$13.7M |
| 2 |
Rentokil
RTO
|
+$7.72M |
| 3 |
Manchester United
MANU
|
+$3.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$6M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$3.63M |
| 3 |
Sun Communities
SUI
|
+$2.46M |
| 4 |
Boston Properties
BXP
|
+$1.62M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 11.52% |
| 2 | Industrials | 9.58% |
| 3 | Real Estate | 2.63% |
| 4 | Communication Services | 2.19% |
| 5 | Financials | 1.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Alexandria Real Estate Equities
ARE
$9.09B
| – | – |
-37,230
| Closed | -$3.63M |
|
|
AVB
27
DELISTED
AvalonBay Communities
AVB
| – | – |
-1,947
| Closed | -$428K |
|
|
28
Boston Properties
BXP
$11.3B
| – | – |
-21,735
| Closed | -$1.62M |
|
|
29
Estee Lauder
EL
$38B
| – | – |
-80,000
| Closed | -$6M |
|
|
30
Sun Communities
SUI
$15.3B
| – | – |
-20,000
| Closed | -$2.46M |
|
Similar funds
Michelson Medical Research Foundation's Q1 2025 Portfolio in Review
As of Q1 2025, Michelson Medical Research Foundation held 30 positions worth $120M, up 0.16% from $119M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Michelson Medical Research Foundation deployed $9.25M of net new capital in Q1 2025, opening 2 new positions and adding to 1 existing holding. Its largest new stake was iShares S&P Small-Cap 600 Value ETF: 129,990 shares worth $12.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Real Estate.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $1.07M trimmed.
- Michelson Medical Research Foundation's largest Q1 2025 buy was iShares S&P Small-Cap 600 Value ETF: 129,990 shares worth $12.7M.
- Michelson Medical Research Foundation added most to Rentokil in Q1 2025, an estimated $7.72M increase.
- Michelson Medical Research Foundation's biggest Q1 2025 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $1.07M.
- Michelson Medical Research Foundation fully exited Estee Lauder in Q1 2025, selling an estimated $6M.
- Michelson Medical Research Foundation's ten largest holdings make up 76% of its $120M portfolio in Q1 2025.
- Michelson Medical Research Foundation opened 2 new positions and closed 5 in Q1 2025.
- Michelson Medical Research Foundation's portfolio value rose 0.16% quarter-over-quarter to $120M.
Based on Michelson Medical Research Foundation's 13F filing for Q1 2025, filed 15 May 2025.